Search Results 3391-3400 of 17084 for pharmacogenetics
Mayo Clinic treats first person in the US with a novel radiopharmaceutical therapy for breast cancer · Mayo Clinic AI tool finds early signs of blood mutations ...
Dr. Ertekin-Taner and her colleagues are exploring the role gene expression changes in the brain in Alzheimer's disease. The team is working to identify genes ...
Mayo Clinic researchers lead discoveries into many conditions, including cancer, Alzheimer's disease and other forms of dementia, as well as how the brain ...
To investigate the efficacy of autologous Epstein-barr virus (EBV)-specific T cells for the treatment of EBV positive Diffuse Large B Cell Lymphoma (DLBCL), ...
'Zombie' cells spark inflammation in severe fatty liver disease, Mayo Clinic researchers find · Joint study finds proton beam therapy helps patients with throat ...
Marla Broadfoot, Ph.D. November 22, 2025. Landmark Mayo Clinic study finds stenting reduces stroke risk in people with carotid artery narrowing featured.
Genetic technology has the potential to significantly improve human health by improving disease risk prediction and guiding prevention strategies.
ROCHESTER, Minn. — Mayo Clinic researchers have identified a specific immune cell that can be targeted to give a boost to standard immunotherapies for cancer.[.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!